Scientists investigate key clues behind coronavirus illness, including its ability to evade the immune system. They aim to design better vaccines and treatments for diseases like pandemic flu. By understanding virus-host interactions, researchers hope to refine their approach to combating emerging public health threats.
A recent study published in The Journal of Infectious Diseases found no association between Kawasaki disease and coronavirus NL63. This conclusion contradicts an earlier study suggesting a potential link, which was later disputed due to selection bias concerns.
Scientists at the University of Texas Medical Branch have discovered a unique mechanism used by the SARS coronavirus to evade the immune system. The virus's nsp1 protein breaks down messenger RNA instructions that trigger the production of interferon beta, crucial for host immunity.
A team of researchers has developed an antiviral inhibitor that is active against several coronaviruses, including those causing the common cold and SARS. The compound targets the main protease enzyme, which is crucial for viral replication, and shows promise as a potential treatment for coronavirus-related diseases.
A novel coronavirus, HCoV-NL63, is strongly associated with croup in children under three years old. The study found that 43% of patients with high viral load and no co-infection had croup, compared to 6% of those without the virus.
A new coronavirus has been found in children with symptoms of Kawasaki disease, a condition that also affects the lungs. The virus was detected in 73% of Kawasaki patients but only 5% of healthy children.
Researchers have successfully developed a human SARS immunisation in animal studies, showing that monkeys vaccinated with the SARS vaccine had antibodies to the virus and no evidence of viral shedding. In contrast, control group monkeys without vaccination showed significant viral shedding after infection.
Researchers believe SARS evolved from a rare recombination of mammalian and avian viruses, enabling it to evade human immune systems. The study sheds light on the evolutionary history of SARS, which may hold clues to designing effective treatments and vaccines.
The article reports on the release of the first peer-reviewed SARS genome sequence, confirming a new variety of coronavirus and providing insights into the virus's molecular components. The genomic sequence is expected to aid in the diagnosis, treatment, and prevention of SARS.
A new human coronavirus has been identified as a likely cause of SARS, according to a study published in The Lancet. The virus was found in 90% of patients with SARS, but its genetic analysis suggests it may have originated from animals.